CAS 114-80-7PubChem CID 8246
Neostigmine Bromide
Neostigmine bromide is the bromide salt of neostigmine. It contains a neostigmine. — ChEBI
- IUPAC name
- [3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium bromide
- Molecular formula
- C12H19BrN2O2
- Molecular weight
- 303.20 g/mol
- Exact mass
- 302.06299 Da
- Topological polar surface area
- 29.5 Ų
- Hydrogen-bond donors
- 0
- Hydrogen-bond acceptors
- 3
- Covalent units
- 2
- Defined stereocentres
- 0
Also known as
Neoserine bromideKirkstigmine bromideEustigmin bromideLeostigmine bromideVagostigminSyntostigmin bromideneo-ProserinProserine bromide
16 more reported names
Stigmanol bromideSynstigmin bromideNeostigmini bromidumPhilostigmin bromideNeo proserineBromure de neostigmineBromuro de neostigminaNeostigmine methyl bromideNeoproserine3-Dimethylcarbamoxyphenyl trimethyl ammonium bromide(m-Hydroxyphenyl)trimethylammonium bromide dimethylcarbamateNSC-757233CHEBI:179557005SYP50G53-Hydroxyphenyltrimethylammonium bromide dimethylcarbamic esterBenzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-, bromide
External database identifiers
- ChEBI:CHEBI:179557
- ChEMBL:CHEMBL54126
- EPA DTXSID:DTXSID9041075
- PubMed:1853
Evidence from additional scientific databases
NIH PubChem PUG-View
Exact identifier match8246
Attributed physical-property, hazard, environmental and use annotations.
- Solubility: >45.5 [ug/mL] (The mean of the results at pH 7.4) Source: Sanford-Burnham Center for Chemical Genomics
- Signal: Danger Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H300 (95.1%): Fatal if swallowed [Danger Acute toxicity, oral]; H310 (95.1%): Fatal in contact with skin [Danger Acute toxicity, dermal]; H315 (97.6%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (95.1%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (97.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H330 (95.1%): Fatal if inhaled [Danger Acute toxicity, inhalation]; H334 (95.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]; H335 (95.1%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P233, P260, P261, P262, P264, P264+P265, P270, P271, P272, P280, P284, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P319, P320, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P361+P364, P362+P364, P403, P403+P233, P405, and P501 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 41 reports by companies from 4 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
Mapped by: Existing checksum-valid CAS to unique PubChem CID match. Retrieved: 2026-08-31. Open source record
Scientific classifications and hazard annotations provide context and do not replace the market-specific regulatory decision shown above.
Additional source coverage and match status
| Source | Result | Checked |
|---|---|---|
| NIH PubChem PUG-View | Exact match | 2026-08-31 |
A recorded no-match is useful evidence that the source was checked; it is not a claim that the substance does not exist elsewhere.
Retrieved from NIH PubChem on 2026-09-02 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.